Key Financial Data Of Reporting Company

Chiome Bioscience Inc. - Filing #7338472

Concept As at
2024-03-31
2024-01-01 to
2024-03-31
2023-01-01 to
2023-12-31
As at
2023-12-31
As at
2023-03-31
2023-01-01 to
2023-03-31
Key financial data of reporting company
Business results of reporting company
Net sales
129,644,000 JPY
682,464,000 JPY
169,404,000 JPY
Ordinary profit (loss)
-303,019,000 JPY
-1,217,240,000 JPY
-227,433,000 JPY
Profit (loss)
-304,024,000 JPY
-1,220,018,000 JPY
-227,683,000 JPY
Equity in earnings (losses) of affiliates if equity method is applied
JPY
JPY
JPY
Share capital
2,587,752,000 JPY
2,388,422,000 JPY
2,097,017,000 JPY
Total number of issued shares
55,720,600 xbrli:shares
52,640,200 xbrli:shares
48,423,500 xbrli:shares
Net assets
1,247,567,000 JPY
1,157,723,000 JPY
1,562,132,000 JPY
Total assets
1,753,934,000 JPY
1,751,454,000 JPY
2,085,676,000 JPY
Dividend paid per share
Basic earnings (loss) per share
-5.60
-24.62
-4.70
Diluted earnings per share
Equity-to-asset ratio
0.704 xbrli:pure
0.651 xbrli:pure
0.743 xbrli:pure

Talk to a Data Expert

Have a question? We'll get back to you promptly.